Pfg Private Wealth Management, LLC Biogen Inc. Transaction History

Pfg Private Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$253.3 - $285.89 $186,175 - $210,129	-735 Reduced 99.46%	4 $1,000
Q2 2023 Jul 17, 2023	SELL	$275.25 - $318.06 $35,782 - $41,347	-130 Reduced 14.96%	739 $210,000
Q1 2023 May 01, 2023	BUY	$256.56 - $292.34 $222,950 - $254,043	869 New	869 $241,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Pfg Private Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Pfg Private Wealth Management, LLC with notifications on news.